New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 14, 2014
09:35 EDTCBMGCellular Biomedicine reports Q2 EPS (85c) vs. (44c) last year
As of June 30, the company had $13.6M in cash and cash equivalents.
News For CBMG From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 20, 2015
09:22 EDTCBMGCellular Biomedicine engages Huntsworth Health to build KOL advocacy for trials
Cellular Biomedicine announced that the company has engaged Huntsworth Health, a global healthcare marketing and communications agency to build a global KOL advocacy campaign for CBMG's ReJoin human adipose-derived mesenchymal progenitor cell, or haMPC, clinical trials for the treatment of Knee Osteoarthritis.
April 7, 2015
12:00 EDTCBMGCellular Biomedicine mentioned cautiously by Pump Stopper blog
Reference Link

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use